Marketing-authorisation holder · United States
Bayer Hlthcare
62 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
62 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 62
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADEMPAS0.5mg | 1.5mg | 1mg | 2.5mg | 2mg · Tablet | Riociguat | United States | Marketed | 2013 |
| ALEVE PM25mg; 220mg · Tablet | Diphenhydramine, Naproxen | United States | Marketed | 2014 |
| ANGELIQ0.25mg; 0.5mg | 0.5mg; 1mg · Tablet | Drospirenone, Estradiol | United States | Marketed | 2005 |
| ANGIOVIST 28260% · Injectable | Diatrizoate | United States | Not marketed | 1982 |
| ANGIOVIST 29252%; 8% · Injectable | Diatrizoate | United States | Not marketed | 1982 |
| ANGIOVIST 37066%; 10% · Injectable | Diatrizoate | United States | Not marketed | 1982 |
| ASTEPRO ALLERGY0.2055mg/spray · Spray, metered | Azelastine | United States | Marketed | 2021 |
| AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER400MG/250ML (1.6MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Moxifloxacin | United States | Not marketed | 2001 |
| BEYAZ3mg,n/a; 0.02mg,n/a; 0.451mg,0.451mg · Tablet | Drospirenone, N/a, Ethinyl estradiol, Levomefolate | United States | Marketed | 2010 |
| BILIVIST500mg · Capsule | Sodium iopodate | United States | Not marketed | 1982 |
| BILTRICIDE600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Praziquantel | United States | Not marketed | 1982 |
| CHILDREN'S ASTEPRO ALLERGY0.2055mg/spray · Spray, metered | Azelastine | United States | Marketed | 2021 |
| CIPRO1200MG/120ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG/20ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG/40ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or e · Injectable | Ciprofloxacin | United States | Not marketed | 1990 |
| CIPRO250mg/5ml | 500mg/5ml · For suspension | Ciprofloxacin | United States | Marketed | 1997 |
| CIPRO250MG BASE | 500MG BASE | 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ciprofloxacin | United States | Marketed | 1987 |
| CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Ciprofloxacin | United States | Not marketed | 1990 |
| CIPRO XR212.6MG; 287.5MG BASE | 212.6MG; 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 425.2MG; 574.9MG BASE | 425.2MG; 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended release | Ciprofloxacin | United States | Marketed | 2002 |
| CLIMARA0.025mg/24hr | 0.0375mg/24hr | 0.05mg/24hr | 0.06mg/24hr | 0.075mg/24hr | 0.1mg/24hr · Film, extended release | Estradiol | United States | Marketed | 1994 |
| CLIMARA PRO0.045mg/24hr; 0.015mg/24hr · Film, extended release | Estradiol, Levonorgestrel | United States | Marketed | 2003 |
| DTIC-DOME100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Dacarbazine | United States | Not marketed | 1975 |
| EOVIST1.8143gm/10ml (181.43mg/ml) | 2.72145gm/15ml (181.43mg/ml) · Solution | Gadoxetic acid | United States | Marketed | 2008 |
| GADAVIST1.20944gm/2ml (604.72mg/ml) | 18.1416gm/30ml (604.72mg/ml) | 39.3068gm/65ml (604.72mg/ml) | 4.5354gm/7.5ml (604.72mg/ml) | 6.0472gm/10ml (604.72mg/ml) | 9.0708gm/15ml (604.72mg/ml) · Solution | Gadobutrol | United States | Marketed | 2011 |
| GASTROVIST66%; 10% · Solution | Diatrizoate | United States | Not marketed | 1982 |
| KERENDIA10mg | 20mg | 40mg · Tablet | Finerenone | United States | Marketed | 2021 |
| KYLEENA19.5mg · System | Levonorgestrel | United States | Marketed | 2016 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 62 | 62 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.